O	O	O	0	10	Activation	Activation	B-NP	NN	O	0	ROOT	O
O	O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T7	B-Entity	B-Entity	14	21	nuclear	nuclear	B-NP	JJ	B-protein	6	NMOD	B-protein
T7	I-Entity	I-Entity	22	28	factor	factor	I-NP	NN	I-protein	6	NMOD	I-protein
T7	I-Entity	I-Entity	29	34	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T7	I-Entity	I-Entity	35	36	B	B	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	37	39	in	in	B-PP	IN	O	1	NMOD	O
O	O	O	40	45	human	human	B-NP	JJ	B-cell_line	11	NMOD	B-cell_line
O	O	O	46	59	neuroblastoma	neuroblastoma	I-NP	NN	I-cell_line	11	NMOD	I-cell_line
O	O	O	60	64	cell	cell	I-NP	NN	I-cell_line	11	NMOD	I-cell_line
O	O	O	65	70	lines	line	I-NP	NNS	I-cell_line	7	PMOD	I-cell_line
O	O	O	70	71	.	.	O	.	O	1	P	O

O	O	O	73	76	The	The	B-NP	DT	O	5	NMOD	O
T8	B-Entity	B-Entity	77	84	nuclear	nuclear	I-NP	JJ	B-protein	5	NMOD	B-protein
T8	I-Entity	I-Entity	85	91	factor	factor	I-NP	NN	I-protein	5	NMOD	I-protein
T8	I-Entity	I-Entity	92	97	kappa	kappa	I-NP	NN	I-protein	5	NMOD	I-protein
T8	I-Entity	I-Entity	98	99	B	B	I-NP	NN	I-protein	12	SUB	I-protein
O	O	O	100	101	(	(	O	(	O	11	DEP	O
T9	B-Entity	B-Entity	101	103	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
T9	I-Entity	I-Entity	103	104	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T9	I-Entity	I-Entity	104	109	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T9	I-Entity	I-Entity	110	111	B	B	I-NP	NN	I-protein	11	DEP	I-protein
O	O	O	111	112	)	)	O	)	O	5	NMOD	O
O	O	O	113	115	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	116	117	a	a	B-NP	DT	O	16	NMOD	O
O	O	O	118	128	eukaryotic	eukaryotic	I-NP	JJ	B-protein	16	NMOD	B-protein
O	O	O	129	142	transcription	transcription	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	143	149	factor	factor	I-NP	NN	I-protein	12	PRD	I-protein
O	O	O	149	150	.	.	O	.	O	12	P	O

O	O	O	151	153	In	In	B-PP	IN	O	7	VMOD	O
O	O	O	154	155	B	B	B-NP	NN	B-cell_type	3	NMOD	B-cell_type
O	O	O	156	161	cells	cell	I-NP	NNS	I-cell_type	5	NMOD	I-cell_type
O	O	O	162	165	and	and	O	CC	O	5	NMOD	O
O	O	O	166	177	macrophages	macrophage	B-NP	NNS	B-cell_type	1	PMOD	B-cell_type
O	O	O	178	180	it	it	B-NP	PRP	O	7	SUB	O
O	O	O	181	183	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	184	198	constitutively	constitutively	B-ADJP	RB	O	9	AMOD	O
O	O	O	199	206	present	present	I-ADJP	JJ	O	7	PRD	O
O	O	O	207	209	in	in	B-PP	IN	O	9	AMOD	O
O	O	O	210	214	cell	cell	B-NP	NN	O	12	NMOD	O
O	O	O	215	221	nuclei	nucleus	I-NP	NNS	O	10	PMOD	O
O	O	O	221	222	,	,	O	,	O	7	P	O
O	O	O	223	230	whereas	whereas	O	IN	O	7	VMOD	O
O	O	O	231	233	in	in	B-PP	IN	O	25	VMOD	O
O	O	O	234	238	many	many	B-NP	JJ	O	19	NMOD	O
O	O	O	239	244	other	other	I-NP	JJ	O	19	NMOD	O
O	O	O	245	249	cell	cell	I-NP	NN	O	19	NMOD	O
O	O	O	250	255	types	type	I-NP	NNS	O	15	PMOD	O
O	O	O	255	256	,	,	O	,	O	25	P	O
T10	B-Entity	B-Entity	257	259	NF	NF	B-NP	NN	B-protein	24	NMOD	B-protein
T10	I-Entity	I-Entity	259	260	-	-	I-NP	HYPH	I-protein	24	NMOD	I-protein
T10	I-Entity	I-Entity	260	265	kappa	kappa	I-NP	NN	I-protein	24	NMOD	I-protein
T10	I-Entity	I-Entity	266	267	B	B	I-NP	NN	I-protein	25	SUB	I-protein
O	O	O	268	280	translocates	translocate	B-VP	VBZ	O	14	SBAR	O
O	O	O	281	285	from	from	B-PP	IN	O	25	VMOD	O
O	O	O	286	293	cytosol	cytosol	B-NP	NN	O	26	PMOD	O
O	O	O	294	296	to	to	B-PP	TO	O	25	VMOD	O
O	O	O	297	304	nucleus	nucleus	B-NP	NN	O	28	PMOD	O
O	O	O	305	307	as	as	B-PP	IN	O	25	VMOD	O
O	O	O	308	309	a	a	B-NP	DT	O	32	NMOD	O
O	O	O	310	316	result	result	I-NP	NN	O	30	PMOD	O
O	O	O	317	319	of	of	B-PP	IN	O	32	NMOD	O
O	O	O	320	332	transduction	transduction	B-NP	NN	O	33	PMOD	O
O	O	O	333	335	by	by	B-PP	IN	O	34	NMOD	O
T1	B-Protein	B-Protein	336	341	tumor	tumor	B-NP	NN	B-protein	39	NMOD	B-protein
T1	I-Protein	I-Protein	342	350	necrosis	necrosis	I-NP	NN	I-protein	39	NMOD	I-protein
T1	I-Protein	I-Protein	351	357	factor	factor	I-NP	NN	I-protein	39	NMOD	I-protein
T1	I-Protein	I-Protein	358	363	alpha	alpha	I-NP	NN	I-protein	51	NMOD	I-protein
O	O	O	364	365	(	(	O	(	O	43	DEP	O
T2	B-Protein	B-Protein	365	368	TNF	TNF	B-NP	NN	B-protein	42	NMOD	B-protein
T2	I-Protein	I-Protein	369	374	alpha	alpha	I-NP	NN	I-protein	43	DEP	I-protein
O	O	O	374	375	)	)	O	)	O	39	NMOD	O
O	O	O	375	376	,	,	O	,	O	51	P	O
O	O	O	377	384	phorbol	phorbol	B-NP	NN	O	46	NMOD	O
O	O	O	385	390	ester	ester	I-NP	NN	O	51	NMOD	O
O	O	O	390	391	,	,	O	,	O	51	P	O
O	O	O	392	395	and	and	O	CC	O	51	NMOD	O
O	O	O	396	401	other	other	B-NP	JJ	O	51	NMOD	O
O	O	O	402	412	polyclonal	polyclonal	I-NP	JJ	O	51	NMOD	O
O	O	O	413	420	signals	signal	I-NP	NNS	O	35	PMOD	O
O	O	O	420	421	.	.	O	.	O	7	P	O

O	O	O	422	427	Using	Use	B-VP	VBG	O	9	VMOD	O
O	O	O	428	441	neuroblastoma	neuroblastoma	B-NP	NN	B-cell_line	4	NMOD	B-cell_line
O	O	O	442	446	cell	cell	I-NP	NN	I-cell_line	4	NMOD	I-cell_line
O	O	O	447	452	lines	line	I-NP	NNS	I-cell_line	1	OBJ	I-cell_line
O	O	O	453	455	as	as	B-PP	IN	O	1	VMOD	O
O	O	O	456	462	models	model	B-NP	NNS	O	5	PMOD	O
O	O	O	462	463	,	,	O	,	O	9	P	O
O	O	O	464	466	we	we	B-NP	PRP	O	9	SUB	O
O	O	O	467	471	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	472	477	shown	show	I-VP	VBN	O	9	VC	O
O	O	O	478	482	that	that	B-SBAR	IN	O	10	VMOD	O
O	O	O	483	485	in	in	B-PP	IN	O	19	VMOD	O
O	O	O	486	492	neural	neural	B-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	O	493	498	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
T11	B-Entity	B-Entity	499	501	NF	NF	I-NP	NN	B-protein	18	NMOD	B-protein
T11	I-Entity	I-Entity	501	502	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T11	I-Entity	I-Entity	502	507	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T11	I-Entity	I-Entity	508	509	B	B	I-NP	NN	I-protein	19	SUB	I-protein
O	O	O	510	513	was	be	B-VP	VBD	O	11	SBAR	O
O	O	O	514	521	present	present	B-ADJP	JJ	O	25	PRD	O
O	O	O	522	524	in	in	B-PP	IN	O	20	AMOD	O
O	O	O	525	528	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	529	536	cytosol	cytosol	I-NP	NN	O	21	PMOD	O
O	O	O	537	540	and	and	O	CC	O	25	VMOD	O
O	O	O	541	553	translocated	translocate	B-VP	VBN	O	19	VC	O
O	O	O	554	558	into	into	B-PP	IN	O	25	VMOD	O
O	O	O	559	565	nuclei	nucleus	B-NP	NNS	O	26	PMOD	O
O	O	O	566	568	as	as	B-PP	IN	O	25	VMOD	O
O	O	O	569	570	a	a	B-NP	DT	O	30	NMOD	O
O	O	O	571	577	result	result	I-NP	NN	O	28	PMOD	O
O	O	O	578	580	of	of	B-PP	IN	O	30	NMOD	O
T3	B-Protein	B-Protein	581	584	TNF	TNF	B-NP	NN	B-protein	34	NMOD	B-protein
T3	I-Protein	I-Protein	585	590	alpha	alpha	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	O	591	600	treatment	treatment	I-NP	NN	O	31	PMOD	O
O	O	O	600	601	.	.	O	.	O	9	P	O

O	O	O	602	605	The	The	B-NP	DT	O	9	NMOD	O
T4	B-Protein	B-Protein	606	609	TNF	TNF	I-NP	NN	B-protein	3	NMOD	B-protein
T4	I-Protein	I-Protein	610	615	alpha	alpha	O	SYM	I-protein	9	NMOD	I-protein
O	O	O	615	616	-	-	O	HYPH	O	3	P	O
O	O	O	616	625	activated	activate	B-NP	VBN	O	9	NMOD	O
T12	B-Entity	B-Entity	626	628	NF	NF	I-NP	NN	B-protein	9	NMOD	B-protein
T12	I-Entity	I-Entity	628	629	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T12	I-Entity	I-Entity	629	634	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T12	I-Entity	I-Entity	635	636	B	B	I-NP	NN	I-protein	10	SUB	I-protein
O	O	O	637	640	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	641	658	transcriptionally	transcriptionally	B-ADJP	RB	O	12	AMOD	O
O	O	O	659	669	functional	functional	I-ADJP	JJ	O	10	PRD	O
O	O	O	669	670	.	.	O	.	O	10	P	O

T13	B-Entity	B-Entity	671	673	NF	NF	B-NP	NN	B-protein	5	NMOD	B-protein
T13	I-Entity	I-Entity	673	674	-	-	I-NP	HYPH	I-protein	5	NMOD	I-protein
T13	I-Entity	I-Entity	674	679	kappa	kappa	I-NP	NN	I-protein	5	NMOD	I-protein
T13	I-Entity	I-Entity	680	681	B	B	I-NP	NN	I-protein	5	NMOD	I-protein
O	O	O	682	692	activation	activation	I-NP	NN	O	9	SUB	O
O	O	O	693	695	by	by	B-PP	IN	O	5	NMOD	O
T5	B-Protein	B-Protein	696	699	TNF	TNF	B-NP	NN	B-protein	8	NMOD	B-protein
T5	I-Protein	I-Protein	700	705	alpha	alpha	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	706	709	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	710	713	not	not	I-VP	RB	O	9	VMOD	O
O	O	O	714	724	correlated	correlate	I-VP	VBN	O	9	VC	O
O	O	O	725	729	with	with	B-PP	IN	O	11	VMOD	O
O	O	O	730	734	cell	cell	B-NP	NN	O	12	PMOD	O
O	O	O	735	750	differentiation	differentiation	I-NP	NN	O	13	NMOD	O
O	O	O	751	753	or	or	I-NP	CC	O	13	NMOD	O
O	O	O	754	767	proliferation	proliferation	I-NP	NN	O	13	NMOD	O
O	O	O	767	768	.	.	O	.	O	9	P	O

O	O	O	769	776	However	However	B-ADVP	RB	O	0	ROOT	O
O	O	O	776	777	,	,	O	,	O	1	AMOD	O
O	O	O	778	786	reagents	reagent	B-NP	NNS	O	2	ROOT	O
O	O	O	787	791	such	such	B-PP	JJ	O	5	PMOD	O
O	O	O	792	794	as	as	I-PP	IN	O	3	NMOD	O
T14	B-Entity	B-Entity	795	800	nerve	nerve	B-NP	NN	B-protein	8	NMOD	B-protein
T14	I-Entity	I-Entity	801	807	growth	growth	I-NP	NN	I-protein	8	NMOD	I-protein
T14	I-Entity	I-Entity	808	814	factor	factor	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	815	816	(	(	O	(	O	11	DEP	O
T15	B-Entity	B-Entity	816	819	NGF	NGF	B-NP	NN	B-protein	11	DEP	B-protein
O	O	O	819	820	)	)	O	)	O	8	NMOD	O
O	O	O	821	824	and	and	O	CC	O	16	NMOD	O
O	O	O	825	828	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	829	836	phorbol	phorbol	I-NP	NN	O	16	NMOD	O
O	O	O	837	842	ester	ester	I-NP	NN	O	16	NMOD	O
O	O	O	843	850	phorbol	phorbol	I-NP	NN	O	40	SUB	O
O	O	O	851	853	12	12	I-NP	CD	O	16	NMOD	O
O	O	O	853	854	-	-	O	HYPH	O	40	P	O
O	O	O	854	863	myristate	myristate	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	O	864	866	13	13	I-NP	CD	I-protein	19	NMOD	I-protein
O	O	O	866	867	-	-	O	HYPH	O	19	P	O
O	O	O	867	874	acetate	acetate	B-NP	NN	O	40	SUB	O
O	O	O	875	876	(	(	O	(	O	25	DEP	O
O	O	O	876	879	PMA	PMA	B-NP	NN	O	25	DEP	O
O	O	O	879	880	)	)	O	)	O	22	NMOD	O
O	O	O	880	881	,	,	O	,	O	22	P	O
O	O	O	882	887	which	which	B-NP	WDT	O	22	NMOD	O
O	O	O	888	894	induce	induce	B-VP	VBP	O	27	SBAR	O
O	O	O	895	907	phenotypical	phenotypical	B-NP	JJ	O	30	NMOD	O
O	O	O	908	923	differentiation	differentiation	I-NP	NN	O	28	OBJ	O
O	O	O	924	926	of	of	B-PP	IN	O	30	NMOD	O
O	O	O	927	930	the	the	B-NP	DT	O	38	NMOD	O
O	O	O	931	933	SH	SH	I-NP	NN	B-cell_line	38	NMOD	B-cell_line
O	O	O	933	934	-	-	B-NP	HYPH	I-cell_line	38	NMOD	I-cell_line
O	O	O	934	938	SY5Y	SY5Y	I-NP	NN	I-cell_line	38	NMOD	I-cell_line
O	O	O	939	952	neuroblastoma	neuroblastoma	I-NP	NN	I-cell_line	38	NMOD	I-cell_line
O	O	O	953	957	cell	cell	I-NP	NN	I-cell_line	38	NMOD	I-cell_line
O	O	O	958	962	line	line	I-NP	NN	I-cell_line	31	PMOD	I-cell_line
O	O	O	962	963	,	,	O	,	O	38	P	O
O	O	O	964	973	activated	activate	B-VP	VBD	O	5	SBAR	O
T16	B-Entity	B-Entity	974	976	NF	NF	B-NP	NN	B-protein	44	NMOD	B-protein
T16	I-Entity	I-Entity	976	977	-	-	B-NP	HYPH	I-protein	44	NMOD	I-protein
T16	I-Entity	I-Entity	977	982	kappa	kappa	I-NP	NN	I-protein	44	NMOD	I-protein
T16	I-Entity	I-Entity	983	984	B	B	I-NP	NN	I-protein	40	OBJ	I-protein
O	O	O	984	985	,	,	O	,	O	40	P	O
O	O	O	986	989	but	but	O	CC	O	40	VMOD	O
O	O	O	990	994	only	only	B-PP	RB	O	48	PMOD	O
O	O	O	995	997	in	in	I-PP	IN	O	40	VMOD	O
O	O	O	998	1002	that	that	B-NP	DT	O	52	NMOD	O
O	O	O	1003	1013	particular	particular	I-NP	JJ	O	52	NMOD	O
O	O	O	1014	1018	cell	cell	I-NP	NN	O	52	NMOD	O
O	O	O	1019	1023	line	line	I-NP	NN	O	48	PMOD	O
O	O	O	1023	1024	.	.	O	.	O	3	P	O

O	O	O	1025	1027	In	In	B-PP	IN	O	14	VMOD	O
O	O	O	1028	1029	a	a	B-NP	DT	O	9	NMOD	O
T17	B-Entity	B-Entity	1030	1033	NGF	NGF	I-NP	NN	B-cell_line	9	NMOD	B-cell_line
O	O	O	1033	1034	-	-	B-NP	HYPH	I-cell_line	9	NMOD	I-cell_line
O	O	O	1034	1044	responsive	responsive	I-NP	JJ	I-cell_line	9	NMOD	I-cell_line
O	O	O	1045	1048	rat	rat	I-NP	NN	I-cell_line	9	NMOD	I-cell_line
O	O	O	1049	1065	pheochromocytoma	pheochromocytoma	I-NP	NN	I-cell_line	9	NMOD	I-cell_line
O	O	O	1066	1070	cell	cell	I-NP	NN	I-cell_line	9	NMOD	I-cell_line
O	O	O	1071	1075	line	line	I-NP	NN	I-cell_line	1	PMOD	I-cell_line
O	O	O	1075	1076	,	,	O	,	O	14	P	O
O	O	O	1077	1081	PC12	PC12	B-NP	NN	B-cell_line	13	NMOD	B-cell_line
O	O	O	1081	1082	,	,	O	,	O	13	P	O
O	O	O	1083	1086	PMA	PMA	B-NP	NN	O	14	SUB	O
O	O	O	1087	1096	activated	activate	B-VP	VBD	O	0	ROOT	O
T18	B-Entity	B-Entity	1097	1099	NF	NF	B-NP	NN	B-protein	18	NMOD	B-protein
T18	I-Entity	I-Entity	1099	1100	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T18	I-Entity	I-Entity	1100	1105	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T18	I-Entity	I-Entity	1106	1107	B	B	I-NP	NN	I-protein	14	OBJ	I-protein
O	O	O	1107	1108	,	,	O	,	O	14	P	O
O	O	O	1109	1116	whereas	whereas	O	IN	O	14	VMOD	O
T19	B-Entity	B-Entity	1117	1120	NGF	NGF	B-NP	NN	B-protein	22	SUB	B-protein
O	O	O	1121	1124	did	do	B-VP	VBD	O	20	SBAR	O
O	O	O	1125	1128	not	not	O	RB	O	22	VMOD	O
O	O	O	1128	1129	.	.	O	.	O	14	P	O

O	O	O	1130	1132	In	In	B-PP	IN	O	25	VMOD	O
O	O	O	1133	1138	other	other	B-NP	JJ	O	5	NMOD	O
O	O	O	1139	1152	neuroblastoma	neuroblastoma	I-NP	NN	B-cell_line	5	NMOD	B-cell_line
O	O	O	1153	1157	cell	cell	I-NP	NN	I-cell_line	5	NMOD	I-cell_line
O	O	O	1158	1163	lines	line	I-NP	NNS	I-cell_line	1	PMOD	I-cell_line
O	O	O	1163	1164	,	,	O	,	O	5	P	O
O	O	O	1165	1169	such	such	B-PP	JJ	O	8	PMOD	O
O	O	O	1170	1172	as	as	I-PP	IN	O	5	NMOD	O
O	O	O	1173	1175	SK	SK	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	1175	1176	-	-	B-NP	HYPH	I-protein	11	P	I-protein
O	O	O	1176	1177	N	N	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	1177	1178	-	-	B-NP	HYPH	O	13	NMOD	O
O	O	O	1178	1180	Be	Be	I-NP	NN	O	8	PMOD	O
O	O	O	1180	1181	(	(	O	(	O	16	DEP	O
O	O	O	1181	1182	2	2	B-NP	CD	O	16	DEP	O
O	O	O	1182	1183	)	)	O	)	O	13	NMOD	O
O	O	O	1183	1184	,	,	O	,	O	25	P	O
O	O	O	1185	1188	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	1189	1193	lack	lack	I-NP	NN	O	25	SUB	O
O	O	O	1194	1196	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	1197	1200	PMA	PMA	B-NP	NN	O	22	NMOD	O
O	O	O	1201	1210	induction	induction	I-NP	NN	O	20	PMOD	O
O	O	O	1211	1213	of	of	B-PP	IN	O	22	NMOD	O
O	O	O	1214	1229	differentiation	differentiation	B-NP	NN	O	23	PMOD	O
O	O	O	1230	1233	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1234	1244	correlated	correlate	I-VP	VBN	O	25	VC	O
O	O	O	1245	1249	with	with	B-PP	IN	O	26	VMOD	O
O	O	O	1250	1253	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	1254	1258	lack	lack	I-NP	NN	O	27	PMOD	O
O	O	O	1259	1261	of	of	B-PP	IN	O	29	NMOD	O
T20	B-Entity	B-Entity	1262	1264	NF	NF	B-NP	NN	B-protein	35	NMOD	B-protein
T20	I-Entity	I-Entity	1264	1265	-	-	B-NP	HYPH	I-protein	35	NMOD	I-protein
T20	I-Entity	I-Entity	1265	1270	kappa	kappa	I-NP	NN	I-protein	35	NMOD	I-protein
T20	I-Entity	I-Entity	1271	1272	B	B	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	O	1273	1283	activation	activation	I-NP	NN	O	30	PMOD	O
O	O	O	1283	1284	.	.	O	.	O	25	P	O

O	O	O	1285	1287	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	1288	1293	found	find	B-VP	VBD	O	0	ROOT	O
O	O	O	1293	1294	,	,	O	,	O	2	P	O
O	O	O	1295	1303	moreover	moreover	B-ADVP	RB	O	2	VMOD	O
O	O	O	1303	1304	,	,	O	,	O	2	P	O
O	O	O	1305	1309	that	that	B-SBAR	IN	O	37	DEP	O
O	O	O	1310	1312	in	in	B-PP	IN	O	25	VMOD	O
O	O	O	1313	1315	SK	SK	B-NP	NN	B-cell_line	16	NMOD	B-cell_line
O	O	O	1315	1316	-	-	B-NP	HYPH	I-cell_line	16	NMOD	I-cell_line
O	O	O	1316	1317	N	N	I-NP	NN	I-cell_line	16	NMOD	I-cell_line
O	O	O	1317	1318	-	-	B-NP	HYPH	I-cell_line	16	NMOD	I-cell_line
O	O	O	1318	1320	Be	Be	I-NP	NN	I-cell_line	16	NMOD	I-cell_line
O	O	O	1320	1321	(	(	O	(	I-cell_line	16	NMOD	I-cell_line
O	O	O	1321	1322	2	2	B-NP	CD	I-cell_line	16	NMOD	I-cell_line
O	O	O	1322	1323	)	)	O	)	I-cell_line	16	NMOD	I-cell_line
O	O	O	1324	1329	cells	cell	B-NP	NNS	I-cell_line	7	PMOD	I-cell_line
O	O	O	1330	1337	protein	protein	I-NP	NN	B-protein	19	NMOD	B-protein
O	O	O	1338	1344	kinase	kinase	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	1345	1346	C	C	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	O	1347	1348	(	(	O	(	O	22	DEP	O
O	O	O	1348	1351	PKC	PKC	B-NP	NN	B-protein	22	DEP	B-protein
O	O	O	1351	1352	)	)	O	)	O	19	NMOD	O
O	O	O	1353	1362	enzymatic	enzymatic	B-NP	JJ	O	24	NMOD	O
O	O	O	1363	1371	activity	activity	I-NP	NN	O	25	SUB	O
O	O	O	1372	1375	was	be	B-VP	VBD	O	6	SBAR	O
O	O	O	1376	1380	much	much	B-ADJP	RB	O	27	AMOD	O
O	O	O	1381	1386	lower	low	I-ADJP	JJR	O	25	PRD	O
O	O	O	1387	1395	compared	compare	B-PP	VBN	O	25	VMOD	O
O	O	O	1396	1400	with	with	B-PP	IN	O	28	VMOD	O
O	O	O	1401	1405	that	that	B-NP	DT	O	29	PMOD	O
O	O	O	1406	1408	in	in	B-PP	IN	O	30	NMOD	O
O	O	O	1409	1410	a	a	B-NP	DT	O	35	NMOD	O
O	O	O	1411	1418	control	control	I-NP	NN	B-cell_line	35	NMOD	B-cell_line
O	O	O	1419	1423	cell	cell	I-NP	NN	I-cell_line	35	NMOD	I-cell_line
O	O	O	1424	1428	line	line	I-NP	NN	I-cell_line	31	PMOD	I-cell_line
O	O	O	1429	1432	and	and	O	CC	O	37	DEP	O
O	O	O	1433	1437	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	1438	1441	the	the	B-NP	DT	O	42	NMOD	O
O	O	O	1442	1445	low	low	I-NP	JJ	O	42	NMOD	O
O	O	O	1446	1449	PKC	PKC	I-NP	NN	B-protein	42	NMOD	B-protein
O	O	O	1450	1459	enzymatic	enzymatic	I-NP	JJ	O	42	NMOD	O
O	O	O	1460	1468	activity	activity	I-NP	NN	O	43	SUB	O
O	O	O	1469	1472	was	be	B-VP	VBD	O	37	SBAR	O
O	O	O	1473	1476	due	due	B-ADJP	JJ	O	43	PRD	O
O	O	O	1477	1479	to	to	B-PP	TO	O	44	AMOD	O
O	O	O	1480	1483	low	low	B-NP	JJ	O	49	NMOD	O
O	O	O	1484	1487	PKC	PKC	I-NP	NN	B-protein	49	NMOD	B-protein
O	O	O	1488	1495	protein	protein	I-NP	NN	O	49	NMOD	O
O	O	O	1496	1506	expression	expression	I-NP	NN	O	45	PMOD	O
O	O	O	1506	1507	.	.	O	.	O	2	P	O

T21	B-Entity	B-Entity	1508	1510	NF	NF	B-NP	NN	B-protein	4	NMOD	B-protein
T21	I-Entity	I-Entity	1510	1511	-	-	I-NP	HYPH	I-protein	4	NMOD	I-protein
T21	I-Entity	I-Entity	1511	1516	kappa	kappa	I-NP	NN	I-protein	4	NMOD	I-protein
T21	I-Entity	I-Entity	1517	1518	B	B	I-NP	NN	I-protein	5	SUB	I-protein
O	O	O	1519	1522	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1523	1526	not	not	I-VP	RB	O	5	VMOD	O
O	O	O	1527	1536	activated	activate	I-VP	VBN	O	5	VC	O
O	O	O	1537	1539	by	by	B-PP	IN	O	7	VMOD	O
O	O	O	1540	1548	retinoic	retinoic	B-NP	JJ	O	10	NMOD	O
O	O	O	1549	1553	acid	acid	I-NP	NN	O	8	PMOD	O
O	O	O	1553	1554	,	,	O	,	O	10	P	O
O	O	O	1555	1560	which	which	B-NP	WDT	O	10	NMOD	O
O	O	O	1561	1568	induced	induce	B-VP	VBD	O	12	SBAR	O
O	O	O	1569	1582	morphological	morphological	B-NP	JJ	O	15	NMOD	O
O	O	O	1583	1598	differentiation	differentiation	I-NP	NN	O	13	OBJ	O
O	O	O	1599	1601	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	1602	1605	all	all	B-NP	PDT	O	21	NMOD	O
O	O	O	1606	1609	the	the	I-NP	DT	O	21	NMOD	O
O	O	O	1610	1623	neuroblastoma	neuroblastoma	I-NP	NN	B-cell_line	21	NMOD	B-cell_line
O	O	O	1624	1628	cell	cell	I-NP	NN	I-cell_line	21	NMOD	I-cell_line
O	O	O	1629	1634	lines	line	I-NP	NNS	I-cell_line	16	PMOD	I-cell_line
O	O	O	1635	1639	used	use	B-VP	VBN	O	21	NMOD	O
O	O	O	1640	1642	in	in	B-PP	IN	O	22	VMOD	O
O	O	O	1643	1646	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	1647	1654	present	present	I-NP	JJ	O	26	NMOD	O
O	O	O	1655	1660	study	study	I-NP	NN	O	23	PMOD	O
O	O	O	1660	1661	.	.	O	.	O	5	P	O

O	O	O	1662	1666	Thus	Thus	B-ADVP	RB	O	8	VMOD	O
O	O	O	1666	1667	,	,	O	,	O	8	P	O
T22	B-Entity	B-Entity	1668	1670	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
T22	I-Entity	I-Entity	1670	1671	-	-	I-NP	HYPH	I-protein	7	NMOD	I-protein
T22	I-Entity	I-Entity	1671	1676	kappa	kappa	I-NP	NN	I-protein	7	NMOD	I-protein
T22	I-Entity	I-Entity	1677	1678	B	B	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	O	1679	1689	activation	activation	I-NP	NN	O	8	SUB	O
O	O	O	1690	1693	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1694	1697	not	not	I-VP	RB	O	8	VMOD	O
O	O	O	1698	1706	required	require	I-VP	VBN	O	8	VC	O
O	O	O	1707	1710	for	for	B-PP	IN	O	10	VMOD	O
O	O	O	1711	1724	neuroblastoma	neuroblastoma	B-NP	NN	B-cell_type	14	NMOD	B-cell_type
O	O	O	1725	1729	cell	cell	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	1730	1745	differentiation	differentiation	I-NP	NN	O	11	PMOD	O
O	O	O	1745	1746	.	.	O	.	O	8	P	O

O	O	O	1747	1758	Furthermore	Furthermore	B-ADVP	RB	O	9	VMOD	O
O	O	O	1758	1759	,	,	O	,	O	9	P	O
O	O	O	1760	1763	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	1764	1771	results	result	I-NP	NNS	O	9	SUB	O
O	O	O	1772	1780	obtained	obtain	B-VP	VBN	O	4	NMOD	O
O	O	O	1781	1785	with	with	B-PP	IN	O	5	VMOD	O
T6	B-Protein	B-Protein	1786	1789	TNF	TNF	B-NP	NN	B-protein	8	NMOD	B-protein
T6	I-Protein	I-Protein	1790	1795	alpha	alpha	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	1796	1802	proved	prove	B-VP	VBD	O	0	ROOT	O
O	O	O	1803	1807	that	that	B-SBAR	IN	O	9	VMOD	O
T23	B-Entity	B-Entity	1808	1810	NF	NF	B-NP	NN	B-protein	15	NMOD	B-protein
T23	I-Entity	I-Entity	1810	1811	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T23	I-Entity	I-Entity	1811	1816	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T23	I-Entity	I-Entity	1817	1818	B	B	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	1819	1829	activation	activation	I-NP	NN	O	16	SUB	O
O	O	O	1830	1833	was	be	B-VP	VBD	O	10	SBAR	O
O	O	O	1834	1837	not	not	O	RB	O	16	VMOD	O
O	O	O	1838	1848	sufficient	sufficient	B-ADJP	JJ	O	16	PRD	O
O	O	O	1849	1852	for	for	B-PP	IN	O	18	AMOD	O
O	O	O	1853	1862	induction	induction	B-NP	NN	O	19	PMOD	O
O	O	O	1863	1865	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	1866	1879	neuroblastoma	neuroblastoma	B-NP	NN	B-cell_type	23	NMOD	B-cell_type
O	O	O	1880	1895	differentiation	differentiation	I-NP	NN	O	21	PMOD	O
O	O	O	1895	1896	.	.	O	.	O	9	P	O
